Ticker: BEAM

Company: Beam Therapeutics Inc.

Person: Bethany J Cavanagh, officer

Transaction date: April 1, 2026

Reporting date: April 6, 2026

Average share price: 24.580000000000002

Sold 3242.0 shares for 79688.36